Roivant Sciences (ROIV) Receivables - Accured (2023 - 2026)

Roivant Sciences' Receivables - Accured history runs 4 years deep, the most recent figure standing at $19.6 million for Q1 2026.

• Quarterly Receivables - Accured rose 61.98% year-over-year to $19.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.6 million (up 61.98% YoY) and the FY2026 annual result came in at $19.6 million, up 61.98% from the prior year.
• Receivables - Accured was $19.6 million for Q1 2026 at Roivant Sciences, up from $12.1 million in the prior quarter.
• Across five years, Receivables - Accured topped out at $27.4 million in Q1 2024 and bottomed at $4.9 million in Q1 2023.
• A 4-year average of $17.8 million and a median of $19.3 million in 2023 frame the typical range for Receivables - Accured.
• Annual changes were most pronounced in 2024 — Receivables - Accured jumped 458.99% — and 2025, when it plunged 55.91%.
• Roivant Sciences' Receivables - Accured stood at $18.9 million in 2023, then rose by 22.68% to $23.2 million in 2024, then plunged by 47.82% to $12.1 million in 2025, then soared by 61.98% to $19.6 million in 2026.
• Business Quant data shows ROIV's Receivables - Accured at $19.6 million in Q1 2026, $12.1 million in Q1 2025, and $23.2 million in Q4 2024.